propranolol has been researched along with Shock, Cardiogenic in 37 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 266 patients entered into a study comparing the effect of intravenous magnesium and propranolol following acute myocardial infarction." | 9.07 | A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction. ( Abraham, AS; Balkin, J; Ilan, M; Klutstein, M; Rosenmann, D; Zion, MM, 1994) |
| "Sixty-three patients with stable, severe typical angina pectoris (New York Heart Association functional class III or IV) were treated with propranolol and studied prospectively with a follow-up period of 5 to 8 years to assess the rate of complications and long-term effectiveness after an initial control period." | 7.65 | Long-term propranolol therapy for angina pectoris. ( Brewer, DL; Orgain, ES; Warren, SG, 1976) |
| "A total of 266 patients entered into a study comparing the effect of intravenous magnesium and propranolol following acute myocardial infarction." | 5.07 | A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction. ( Abraham, AS; Balkin, J; Ilan, M; Klutstein, M; Rosenmann, D; Zion, MM, 1994) |
| "Sixty-three patients with stable, severe typical angina pectoris (New York Heart Association functional class III or IV) were treated with propranolol and studied prospectively with a follow-up period of 5 to 8 years to assess the rate of complications and long-term effectiveness after an initial control period." | 3.65 | Long-term propranolol therapy for angina pectoris. ( Brewer, DL; Orgain, ES; Warren, SG, 1976) |
| " A publication reported a patient treated with HDI with plasma insulin concentrations >1000 µU/mL and elimination half-life 10-18 h requiring intravenous glucose replacement for >5 days." | 1.72 | Variability in insulin pharmacokinetics following high-dose insulin therapy. ( Haber, PS; Hughes, HK; Jones, GRD; Roberts, DM, 2022) |
| "Cardiogenic shock was induced in healthy pigs with a bolus of 0." | 1.56 | Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning. ( Cole, JB; Corcoran, JN; Engebretsen, KM; Stellpflug, SJ, 2020) |
| " Standard recommendations for dosing of insulin vary and the optimal dose of HDI in PICS has not been established." | 1.39 | A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock. ( Adams, AB; Anderson, CP; Cole, JB; Ellsworth, H; Engebretsen, KM; Holger, JS; Stellpflug, SJ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (78.38) | 18.7374 |
| 1990's | 1 (2.70) | 18.2507 |
| 2000's | 3 (8.11) | 29.6817 |
| 2010's | 2 (5.41) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, DM | 1 |
| Hughes, HK | 1 |
| Haber, PS | 1 |
| Jones, GRD | 1 |
| Cole, JB | 2 |
| Corcoran, JN | 1 |
| Engebretsen, KM | 3 |
| Stellpflug, SJ | 3 |
| Katzung, KG | 1 |
| Leroy, JM | 1 |
| Boley, SP | 1 |
| Holger, JS | 3 |
| Ellsworth, H | 1 |
| Anderson, CP | 1 |
| Adams, AB | 1 |
| Ablorh, NA | 1 |
| Nitu, F | 1 |
| Engebretsen, K | 1 |
| Thomas, DD | 1 |
| Boyd, R | 1 |
| Ghosh, A | 1 |
| Nakamura, T | 1 |
| Sugawara, Y | 1 |
| Ishida, T | 1 |
| Ikeda, N | 1 |
| Funayama, H | 1 |
| Yasu, T | 1 |
| Kubo, N | 1 |
| Fujii, M | 1 |
| Kawakami, M | 1 |
| Takanashi, S | 1 |
| Saito, M | 1 |
| Hoffbrand, BI | 1 |
| Anshelevich, IuV | 1 |
| Dumesh, SZ | 1 |
| Slaĭdyn', AK | 1 |
| Sporan, VG | 1 |
| Rudolph, W | 1 |
| Dirschinger, J | 1 |
| Salzberg, MR | 1 |
| Gallagher, EJ | 1 |
| Balkin, J | 1 |
| Rosenmann, D | 1 |
| Ilan, M | 1 |
| Klutstein, M | 1 |
| Zion, MM | 1 |
| Abraham, AS | 1 |
| Cairns, JA | 1 |
| Langou, RA | 1 |
| Geha, AS | 1 |
| Hammond, GL | 1 |
| Cohen, LS | 1 |
| Warren, SG | 1 |
| Brewer, DL | 1 |
| Orgain, ES | 1 |
| Denis, B | 1 |
| Pellet, J | 1 |
| Machecourt, J | 1 |
| Martin-Noël, P | 1 |
| Robert, M | 1 |
| Boyer, NH | 1 |
| Bloch, A | 1 |
| Beller, GA | 1 |
| DeSanctis, RW | 1 |
| Mundth, ED | 1 |
| Buckley, MJ | 1 |
| Daggett, WM | 1 |
| McEnamy, MT | 1 |
| Leinbach, RC | 1 |
| Gold, HD | 1 |
| Austen, WG | 1 |
| Swanson, H | 1 |
| Beauchamp, GD | 1 |
| Bell, H | 1 |
| Kindred, L | 1 |
| Lane, AS | 1 |
| Woodward, AC | 1 |
| Goldman, MR | 1 |
| Urbaszek, W | 2 |
| Günther, K | 2 |
| Kones, RJ | 1 |
| Bregman, D | 2 |
| Parodi, EN | 2 |
| Malm, JR | 2 |
| Pantridge, JF | 1 |
| Lefemine, AA | 1 |
| Flessas, A | 1 |
| Moon, HS | 1 |
| Jenkins, WL | 1 |
| Le Pailleur, C | 1 |
| Meilhac, B | 1 |
| Neveux, JY | 1 |
| Mathey, J | 1 |
| Di Matteo, J | 1 |
| Reemtsma, K | 1 |
| Patton, RD | 1 |
| Verstraete, M | 1 |
| Lozano, JR | 1 |
| Corday, E | 1 |
| Carrasco, HA | 1 |
| Lang, TW | 1 |
| Meerbaum, S | 1 |
| Achenbach, H | 1 |
| Splith, G | 1 |
| Trenckmann, H | 1 |
| Liebold, F | 1 |
| Feola, M | 1 |
| Haiderer, O | 1 |
| Kennedy, JH | 1 |
| Torsti, P | 1 |
| Grossman, JI | 1 |
| Furman, S | 1 |
4 reviews available for propranolol and Shock, Cardiogenic
| Article | Year |
|---|---|
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Glucagon for the treatment of symptomatic beta blocker overdose.
Topics: Adrenergic beta-Antagonists; Adult; Drug Overdose; Emergencies; Evidence-Based Medicine; Female; Glu | 2003 |
Myocardial infarction size: measurement and modification.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Disease; Creatine Kinase; Digitalis Glycoside | 1977 |
Cardiogenic shock: therapeutic implications of altered myocardial energy balance.
Topics: Adrenergic alpha-Antagonists; Aerobiosis; Anaerobiosis; Angiotensin II; Assisted Circulation; Blood | 1974 |
Management of arrhythmias in acute myocardial infarction.
Topics: Acid-Base Equilibrium; Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac O | 1971 |
2 trials available for propranolol and Shock, Cardiogenic
| Article | Year |
|---|---|
A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction.
Topics: Aged; Female; Heart Block; Humans; Incidence; Infusions, Intravenous; Injections, Intravenous; Magne | 1994 |
The difficulty of appraisal of streptokinase treatment of myocardial infarction.
Topics: Anti-Arrhythmia Agents; Clinical Trials as Topic; Coronary Care Units; Glucocorticoids; Glucose; Hep | 1971 |
31 other studies available for propranolol and Shock, Cardiogenic
| Article | Year |
|---|---|
Variability in insulin pharmacokinetics following high-dose insulin therapy.
Topics: Administration, Intravenous; Humans; Hypoglycemia; Insulin; Male; Propranolol; Shock, Cardiogenic | 2022 |
Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotoxicity; Disease Models, Animal; Drug Administration Sc | 2020 |
A randomized controlled study comparing high-dose insulin to vasopressors or combination therapy in a porcine model of refractory propranolol-induced cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Animals; Arterial Pressure; Disease Models, Animal; Drug Therapy, Combi | 2019 |
A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Inbred Strains; Arterial Pressure; Blood Glucose; Car | 2013 |
Insulin-dependent rescue from cardiogenic shock is not mediated by phospholamban phosphorylation.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Calcium Channel Blockers; Calcium-Binding Proteins; H | 2009 |
Recurrent cardiogenic shock caused by dynamic mitral regurgitation in a patient with hypertrophic obstructive cardiomyopathy: a case report.
Topics: Adrenergic beta-Antagonists; Aged; Cardiomyopathy, Hypertrophic; Combined Modality Therapy; Heart Va | 2005 |
Beta-adrenergic blockage in congestive cardiomyopathy.
Topics: Aged; Cardiac Complexes, Premature; Cardiomyopathies; Female; Heart Failure; Humans; Propranolol; Pu | 1980 |
[Complications after intravenous administration of anti-arrhythmia agents].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Ad | 1982 |
[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
Topics: Analgesics; Atropine; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart | 1981 |
Propranolol overdose.
Topics: Adult; Emergencies; Female; Glucagon; Humans; Hypotension; Myocardial Contraction; Propranolol; Shoc | 1980 |
Surgical approach for patients with unstable angina pectoris: role of the response to initial medical therapy and intraaortic balloon pumping in perioperative complications after aortocoronary bypass grafting.
Topics: Administration, Oral; Angina Pectoris; Assisted Circulation; Cardiac Catheterization; Coronary Arter | 1978 |
Long-term propranolol therapy for angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Asthma; Blood Pressure; Female; Heart Failure; Humans; Middle Aged; Ni | 1976 |
[Verapamil and beta blockader: a hazardous therapeutic combination].
Topics: Aged; Drug Therapy, Combination; Female; Heart; Humans; Middle Aged; Propranolol; Shock, Cardiogenic | 1977 |
[Intensive care in the elderly patient. Clinical aspects (author's transl)].
Topics: Acute Kidney Injury; Aged; Dyspnea; Female; Humans; Intensive Care Units; Male; Micrognathism; Middl | 1977 |
Letter: Hypothermia in acute myocardial infarction defended.
Topics: Animals; Dogs; Humans; Hypothermia, Induced; Myocardial Infarction; Myocardium; Oxygen Consumption; | 1976 |
Chronic propranolol administration and acute myocardial infarction.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Shock, Cardiogen | 1976 |
Intra-aortic ballon pump assistance and early surgery in cardiogenic shock.
Topics: Animals; Assisted Circulation; Boston; Coronary Circulation; Electrocardiography; Humans; Myocardial | 1975 |
Reversible cardiogenic shock after low dose oral propranolol.
Topics: Administration, Oral; Aged; Bradycardia; Confusion; Humans; Hypotension; Male; Middle Aged; Oliguria | 1975 |
Massive propranolol overdose poorly responsive to pharmacologic therapy: use of the intra-aortic balloon pump.
Topics: Adolescent; Electric Countershock; Female; Humans; Intra-Aortic Balloon Pumping; Propranolol; Resusc | 1987 |
[Effectiveness of electric double stimulation of the heart in hypodynamic heart circulation situation].
Topics: Animals; Blood Circulation; Cardiac Complexes, Premature; Coronary Circulation; Coronary Vessels; Do | 1971 |
Left ventricular and unidirectional intra-aortic balloon pumping. Effects on hemodynamics in canine cardiogenic shock.
Topics: Animals; Assisted Circulation; Cardiac Output; Coronary Circulation; Coronary Vessels; Dogs; Heart; | 1974 |
Letter: Infarction in patients treated with propranolol.
Topics: Angina Pectoris; Atropine; Heart Rate; Humans; Injections; Myocardial Infarction; Propranolol; Shock | 1974 |
Left ventricular bypass for ventricular failure. Technical and hemodynamic considerations.
Topics: Animals; Aorta, Thoracic; Assisted Circulation; Cardiac Output; Constriction; Coronary Vessels; Dogs | 1973 |
Some aspects of the treatment of shock in animals.
Topics: Adrenal Cortex Hormones; Animals; Blood Pressure; Blood Transfusion; Cardiac Output; Digitalis Glyco | 1972 |
[Assisted circulation by intra-aortic counter-pulsation. Experimental study].
Topics: Animals; Aorta; Assisted Circulation; Blood Pressure; Catheterization; Dogs; Electrocardiography; He | 1973 |
Unidirectional balloon pumping in the inferior vena cava and aorta. Effects on canine hemodynamics in cardiogenic shock.
Topics: Animals; Aorta; Aorta, Thoracic; Assisted Circulation; Blood Flow Velocity; Blood Pressure; Cardiac | 1974 |
Pharmacodynamic application of L-dopa in cardiogenic shock.
Topics: Animals; Aorta; Blood Pressure; Coronary Circulation; Dihydroxyphenylalanine; Disease Models, Animal | 1972 |
[Hemodynamics of hypodynamic heart circulation in animal experiments with use of intra-aortic balloon pulsation and electric double-stimulation of the heart].
Topics: Animals; Aorta; Coronary Circulation; Coronary Vessels; Dogs; Electric Stimulation; Heart; Hemodynam | 1971 |
Experimental graded "pump failure" of the left ventricle.
Topics: Animals; Aorta, Thoracic; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cardiac Output; Cardi | 1971 |
[The use of sympathomimetics and sympatholytics in shock].
Topics: Chlorpromazine; Dopamine; Humans; Isoproterenol; Metaraminol; Norepinephrine; Phenoxybenzamine; Phen | 1971 |
Intra-aortic balloon augmentation durng drug-induced myocardial depression.
Topics: Animals; Aorta, Thoracic; Assisted Circulation; Blood Pressure; Cardiac Output; Dogs; Electrocardiog | 1971 |